|
|
platinum sponsor
gold sponsors
silver sponsor
session sponsors
exhibitor
Pharma & Biotech Supply Chain Asia 2010 will bring new thinking perspectives on the new opportunities, regulatory policies and collaboration strategies necessary to address unique and specific challenges and achieve profitable business models.
Interested to speak at the event?
Contact Stella Teo at +65 6322 2757 or email stella.teo@terrapinn.com
| |
Target your market!
For details contact
Stella Teo
|
|
|
|
|
17 March 2010 Conference Day One 17 March 2010 Conference Day One
8am Registration and refreshments OPENING LEADERSHIP ROUNDTABLE DISCUSSION9.15am Cultivating entrepreneurships in biopharmaceutical industry of Asia and beyondEntrepreneurship, whether being a start-up or within an organization, is a key driver of our economy. Wealth and a high majority of jobs are created by small businesses started by entrepreneurially minded individuals, many of whom go on to create big businesses. Gearing up for a global gravity shift towards Asia, biopharma entrepreneurs are facing a wealth of opportunities. What are the success factors that Asia’s emerging biopharma business leaders employ to capture the growth of the industry? Find out the trade secrets when we take you through the journey of entrepreneurship with the most successful entrepreneurs from Asia
- The promises and challenges of Asia’s biopharmaceutical market in an era of healthcare reform
- Looking into the business opportunities in Asia to drive growth and global expansion for Asian and global players
- Finding the right business model and strategy to achieve success in the Asian and global biopharmaceutical arena
Host:
Mr Peter Kash, President, Riverbank Capital Securities
Interviewees:
Mr Israel Makov, Chairman, Given Imaging, Chairman, Netafi m, Former President and Chief Executive Officer, Teva Pharmaceutical
Dr Villo Morawala-Patell, Founder, Chairperson & Managing Director, Avesthagen Limited 10.15am Morning refreshment and exhibition opening PHARMA & BIOTECH SUPPLY CHAIN ASIA CHARTING A FLEXIBLE SUPPLY CHAIN STRATEGY WHILE MAINTAINING REGULATORY COMPLIANCE 11am Chairperson Opening RemarksJames Payne, Director, Business Solutions, Contract Management and Commercial, Global Account Management Asia Pacific, TNT Express 11.05am Preparing and modifying your supply chain models to cope with future expansion in manufacturing biologic products.
- Review how supply chain models evolve to accommodate temperature and highly regulated biologic drugs
- Reviewing what are the current trends and changes in Asia for accommodating biologic production?
- How to develop a flexible supply chain to accommodate generic vs. biologic manufacturing production?
VP Global Quality & Divisional Export Control, Roche Diagnostics GmbH
11.30am Effectively optimise and ensure control in your global/regional supply chain to achieve product integrity and supply chain visibility
- Strategies in tightening today's fragmented supply chain through your outsourcing partners and suppliers
- Balancing the need for service level and costs with quality
- TNT's case study: How to realign and minimise touchpoints in your supply chain to improve product integrity and visibility
Mr Damian Tan, Managing Director, TNT Express
12pm GxP compliance – The Courier/ Transportation perspective
- The Regulators – Status of current regulations
- The Regulated – Who and how to comply with GxP regulations
- Daily distribution challenges – Focus on investigational drugs
- Potential solutions – A look at GxP compliant services
Global Director, Quality & Technical Compliance, World Courier Management
12.30pm Afternoon networking refreshment break PROTECTING YOUR INBOUND & OUTBOUND SUPPLY CHAIN TO ACHIEVE PRODUCT SAFETY AND QUALITY
1.30pm Inbound strategy – Sourcing from China: Developing an
effective and strategic supplier model without comprising
product quality
- Reviewing the weakness in traditional outsourcing models
- Establishing possible framework and solutions such as quality surveillance processes and proactive steps to
mitigate risks
- Co-development as the new trend?
Ying Luo, President and CEO, Shanghai Genomics 2pm Supplier - buyer collaboration panel: Reduce prevailing risk in your key supply chain partners
- Addressing the challenges in supplier-buyer collaboration and the importance to achieve product integrity
- Sourcing strategies that ensure long term supplies of essential material and business continuity
- Utilising risk assessment to manage and improve supplier management relationship
- Reviewing what is the right partnership model and amount of control is required over your key supply chain partners
- Reviewing the right technologies to increase security and gain visibility in supply chain
Ying Luo, President and CEO, Shanghai Genomics, China
VP Global Quality & Divisional Export Control, Roche Diagnostics GmbH Senior Director Clinical Research, PharmaNet Singapore Mr Tim Sensenig, VP Global Business Development & Sales, Four Soft Limited
3.30pm Afternoon Refreshments and one to one meetings
SUPPLY CHAIN PLANNING AND DEMAND FORECASTING TO ACHIEVE COST OPTIMISATION, HIGHER CUSTOMER SERVICE LEVEL AND SPEED TO MARKET4pm Building an integrated and visible supply chain network: Partnering with key supply chain stakeholders to drive accurate Demand Forecasting
- Building an effective Demand Forecasting framework through enhanced S&OP strategies to improve inventory visibility
- Critical forecasting methodology that is both fluid and flexible
- Driving Supplier and Customer Relationships to improve Demand Fulfillment
Daryll Mascarenhas, General Manager Supply Chain, GlaxoSmithKline Pharmaceutical 4.30pm Achieving effective & successful trial throu accurate demand forecasting of Clinical supplies
- Overcoming" supplies stock out" situation through effective demand forecasting
- Building an effective aggregate demand forecasting startegy at the distribution point
- How to ensure infrastructure of local depot network for clinical supplies are ready to achieve operation & cost
Mr S. M. Sapatnekar, Medical Doctor, Karmic Lifesciences Ltd.
5pm Essential strategies to achieve success in managing global clinical supply chain in Asia
- Overcoming key challenges in managing clinical trial across Asia Pacific
- Examining the clinical supply chain in Asia and identifying the weak link
- Overcoming country to country regulations and compliance in importing investigation product across multiple sites in Asia
Senior Director Clinical Research, PharmaNet Singapore
5.30pm Chairman's Closing Remarks & Networking Cocktail
|
|
|
|
|
Unleashing Excellence in End to End Cold Chain Strategies
Led by:
This workshop is tailored for professionals managing or directly involved in handling of investigational drugs and vaccines, biotechnology products, biological products, biological specimens, sampling kits and temperature-controlled drug shipments.
 Sherman Cheung, Director of Supply Chain Management, Sanofi Pasteur, Canada
 Siddhartha Pahwa, President - Global Supply Chain,
Piramal Healthcare Ltd
 Viliam Kovac,
VP, Global Quality & Divisional Export Control,
Roche Diagnostics GmbH
 Dr Ying Luo,
President and CEO, Shanghai Genomics, China
 Xiao Hei Wen,
Director Supply Chain, Sanofi-Aventis, Singapore
 Onno Boots,
Regional Managing Director,
TNT Express
 Andrew Mcdonald, Director, Operation- Asia Pacific
World Courier
 Dr Ruediger Lomb
Global Director, Quality & Technical Compliance
World Courier
Georg Schulz
Business Development Director
Zuellig Pharma SSG
>> view programme
|
Pharma & Biotech Supply Chain Asia 2010 will bring new thinking perspectives on the new opportunities, regulatory policies and collaboration strategies necessary to address unique and specific challenges and achieve profitable business models.
Interested to speak at the event?
Contact Stella Teo at +65 6322 2757 or email stella.teo@terrapinn.com
| |
Target your market!
For details contact
Stella Teo
|
|
|
|
|
|
